According to the development strategy and actual situation of the controlling shareholder of Xinjiang Bai Hua Cun Pharma Tech, based on careful study and consultation with the issuer, the company has decided to terminate the issuance of stocks to specific parties and to apply for the withdrawal of relevant application documents from the Shanghai Stock Exchange.
百花医药：终止向特定对象发行股票事项
Xinjiang Bai Hua Cun Pharma Tech: terminates the issuance of stocks to specific recipients.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.